INM - InMed Pharmaceuticals Inc.
3.16
0.030 0.949%
Share volume: 1,559
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.42%
PREVIOUS CLOSE
CHG
CHG%
$3.13
0.03
0.96%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 2024-05-13 | 2024-11-14 | 2024-11-14 | |
| Cash flow financing | 0.000 | 176.000 | 838.239 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | 0.000 | -988.571 K | |
| Net income | -1.723 M | -1.938 M | -1.678 M | |
| Depreciation | 54.770 K | 54.767 K | 54.579 K | |
| Changes in inventories | 0.000 | 0.000 | -24.251 K | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.000 | 0.000 | 0.000 | |
| Cash Change | -1.934 M | -1.029 M | -988.571 K |